{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:49:09Z","timestamp":1790812149644,"version":"4.1.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamainternmed.2019.0392","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:05:11Z","timestamp":1559041511000},"page":"898","source":"Crossref","is-referenced-by-count":63,"title":["Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid Lowering Arm"],"prefix":"10.1001","volume":"179","author":[{"given":"Samia","family":"Mora","sequence":"first","affiliation":[{"name":"Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lan","family":"Chang","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Vinayaga","family":"Moorthy","sequence":"additional","affiliation":[{"name":"Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Sever","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"25","key":"ioi190017r1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"ioi190017r2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jacc.2015.12.047","article-title":"Fasting or nonfasting lipid measurements: it depends on the question.","volume":"67","author":"Driver","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"ioi190017r3","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","article-title":"Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points: a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"ioi190017r4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jamainternmed.2016.1979","article-title":"Nonfasting for routine lipid testing: from evidence to action.","volume":"176","author":"Mora","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"18","key":"ioi190017r5","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease.","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"issue":"10","key":"ioi190017r6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.108.777334","article-title":"Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.","volume":"118","author":"Mora","year":"2008","journal-title":"Circulation"},{"issue":"20","key":"ioi190017r7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","article-title":"Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.","volume":"118","author":"Langsted","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"ioi190017r8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"ioi190017r9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.114.010001","article-title":"Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III).","volume":"130","author":"Doran","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"ioi190017r10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1373\/clinchem.2015.247866","article-title":"Nonfasting sample for the determination of routine lipid profile: is it an idea whose time has come?","volume":"62","author":"Rifai","year":"2016","journal-title":"Clin Chem"},{"issue":"6","key":"ioi190017r11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/00004872-200106000-00020","article-title":"Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial.","volume":"19","author":"Sever","year":"2001","journal-title":"J Hypertens"},{"issue":"9364","key":"ioi190017r12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"issue":"19","key":"ioi190017r13","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"ioi190017r14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamacardio.2018.1533","article-title":"Comparison of low-density lipoprotein cholesterol assessment by Martin\/Hopkins estimation, Friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER trial.","volume":"3","author":"Martin","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"4","key":"ioi190017r15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"issue":"7","key":"ioi190017r16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1373\/clinchem.2016.258897","article-title":"Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cutpoints: a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.","volume":"62","author":"Nordestgaard","year":"2016","journal-title":"Clin Chem"},{"issue":"7","key":"ioi190017r17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol: a Consensus Statement from EAS and EFLM.","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin Chem"},{"issue":"5","key":"ioi190017r18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cjca.2016.02.066","article-title":"Hypertension Canada\u2019s 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.","volume":"32","author":"Leung","year":"2016","journal-title":"Can J Cardiol"},{"issue":"11","key":"ioi190017r19","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult.","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"issue":"13","key":"ioi190017r20","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","article-title":"A test in context: lipid profile, fasting versus nonfasting.","volume":"70","author":"Nordestgaard","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ioi190017r21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.117.031857","article-title":"The future of low-density lipoprotein cholesterol in an era of nonfasting lipid testing and potent low-density lipoprotein lowering.","volume":"137","author":"Farukhi","year":"2018","journal-title":"Circulation"},{"key":"ioi190017r22","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","author":"Gundy","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"ioi190017r23","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archinternmed.2012.3708","article-title":"Fasting time and lipid levels in a community-based population: a cross-sectional study.","volume":"172","author":"Sidhu","year":"2012","journal-title":"Arch Intern Med"},{"issue":"5","key":"ioi190017r24","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.2337\/dc10-2402","article-title":"Hypoglycemia in patients with diabetes on antidiabetic medications who fast for laboratory tests.","volume":"34","author":"Aldasouqi","year":"2011","journal-title":"Diabetes Care"},{"key":"ioi190017r25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4236\/ijcm.2016.710071","article-title":"Fasting for lipid profiles poses a high risk of hypoglycemia in patients with diabetes: a pilot prevalence study in clinical practice.","volume":"7(10)","author":"Aldasouqi","year":"2016","journal-title":"Int J Clin Med"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamainternalmedicine\/article-pdf\/179\/7\/898\/17690734\/jamainternal_mora_2019_oi_190017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T11:02:09Z","timestamp":1561978929000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2019.0392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2019.0392","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}